gsk

Too Late To Short Glaxosmithkline

It may be too late to short Glaxosmithkline (GSK) but so what. The fourth biggest company in “Big Pharma” just pled guilty and will pay a fine of $3 Billion in the largest health care fraud case in United States history. When the settlement was announced the stock fell from $1481 a share to $1487 […]

Continue Reading
Home Privacy Policy Terms Of Use Contact Us Affiliate Disclosure DMCA Earnings Disclaimer